IP Library Granted Patent US 8,049,035
Granted Patent B2
US 8,049,035 · App. 13/022,139 · Granted Nov 1, 2011

Crystalline potassium salt of lipoxin A

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,049,035
App. No.
13/022,139
Granted
Nov 1, 2011
Kind
B2
Abstract

This invention is directed to the crystalline potassium salt of a lipoxin A 4 analog of Formula (I): processes for preparing the crystalline potassium salts, methods for using them to treat disease-states characterized by inflammation, and pharmaceutical compositions comprising such crystalline potassium salts.

Claims (98)

1. A method for preparing a crystalline potassium salt of 2-((2S,3R,4E,6E,10E,12S)-13-(4-fluorophenoxy)-2,3,12-trihydroxytridec a-4,6,10-trien-8-ynyloxy)acetate:

which is

in the form of a monohydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.5 Å;

in the form of a monohydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.5 Å, about d=4.3 Å and about d=4.0 Å;

in the form of a dihydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=27.1 Å; or

in the form of a dihydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=27.1 Å, about d=4.2 Å and about d=4.1 Å,

comprising

1) mixing together a potassium base present in ethanol and/or water, with the free acid corresponding to the salt of Formula (I) present in ethanol and/or water; wherein the resultant suspension contains water;

2) optionally cooling the resulting suspension;

3) isolating the resulting crystals from the resulting suspension;

4) optionally washing the isolated crystals with an ethanol/water mixture; and

5) drying the isolated crystals, to give the crystalline potassium salt (I);

or which is

in the form of an anhydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.7 Å; or

in the form of an anhydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.7 Å and about d=3.7 Å;

comprising

1) digesting a hydrate or a mixture of hydrates of a potassium salt of Formula (I) in 1,4-dioxane;

2) optionally heating the resulting suspension;

3) isolating the resulting crystals;

4) optionally washing the isolated crystals with 1,4-dioxane; and

5) drying the isolated crystals, to give the crystalline anhydrate form of the potassium salt (I).

2. The method according to claim 1 , wherein the crystalline potassium salt prepared is in the form of a monohydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.5 Å.

3. The method according to claim 1 , wherein the crystalline potassium salt prepared is in the form of a monohydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.5 Å, about d=4.3 Å and about d=4.0 Å.

4. The method according to claim 1 , wherein the crystalline potassium salt prepared is in the form of a dihydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=27.1 Å.

5. The method according to claim 1 , wherein the crystalline potassium salt prepared is in the form of a dihydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=27.1 Å, about d=4.2 Å and about d=4.1 Å.

6. The method according to claim 1 , wherein the crystalline potassium salt prepared is in the form of an anhydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.7 Å.

7. The method according to claim 1 , wherein the crystalline potassium salt prepared is in the form of an anhydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.7 Å and about d=3.7 Å.

8. The method according to claim 1 , wherein the crystalline potassium salt prepared has the X-ray powder diffraction patterns illustrated in FIG. 2 and is a monohydrate.

9. The method according to claim 1 , wherein the crystalline potassium salt prepared has the X-ray powder diffraction patterns illustrated in FIG. 2 and is a dihydrate.

10. A method according to claim 1 for preparing a crystalline potassium salt of 2-((2S,3R,4E,6E,10E,12S)-13-(4-fluorophenoxy)-2,3,12-trihydroxytridec a-4,6,10-trien-8-ynyloxy)acetate:

which is

in the form of a monohydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.5 Å;

in the form of a monohydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.5 Å, about d=4.3 Å and about d=4.0 Å;

in the form of a dihydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=27.1 Å; or

in the form of a dihydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=27.1 Å, about d=4.2 Å and about d=4.1 Å,

comprising

1) mixing together a potassium base present in ethanol and/or water, with the free acid corresponding to the salt of Formula (I) present in ethanol and/or water; wherein the resultant suspension contains water;

2) optionally cooling the resulting suspension;

3) isolating the resulting crystals from the resulting suspension;

4) optionally washing the isolated crystals with an ethanol/water mixture; and

5) drying the isolated crystals, to give the crystalline potassium salt (I).

11. The method according to claim 10 , which comprises

1) mixing together a potassium base present in ethanol and/or water, with the free acid corresponding to the salt of Formula (I) present in ethanol and/or water; wherein the resultant suspension contains water;

2) cooling the resulting suspension;

3) isolating the resulting crystals from the resulting suspension;

4) optionally washing the isolated crystals with an ethanol/water mixture; and

5) drying the isolated crystals, to give the crystalline potassium salt (I).

12. The method according to claim 10 , which comprises

1) mixing together a potassium base present in ethanol and/or water, with the free acid corresponding to the salt of Formula (I) present in ethanol and/or water; wherein the resultant suspension contains water;

2) optionally cooling the resulting suspension;

3) isolating the resulting crystals from the resulting suspension;

4) washing the isolated crystals with an ethanol/water mixture; and

5) drying the isolated crystals, to give the crystalline potassium salt (I).

13. The method according to claim 10 , which comprises

1) mixing together a potassium base present in ethanol and/or water, with the free acid corresponding to the salt of Formula (I) present in ethanol and/or water; wherein the resultant suspension contains water;

2) cooling the resulting suspension;

3) isolating the resulting crystals from the resulting suspension;

4) washing the isolated crystals with an ethanol/water mixture; and

5) drying the isolated crystals, to give the crystalline potassium salt (I).

14. A method according to claim 1 for preparing a crystalline potassium salt of 2-((2S,3R,4E,6E,10E,12S)-13-(4-fluorophenoxy)-2,3,12-trihydroxytrideca-4,6,10-trien-8-ynyloxy)acetate:

which is

in the form of an anhydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.7 Å; or

in the form of an anhydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.7 Å and about d=3.7 Å;

comprising

1) digesting a hydrate or a mixture of hydrates of a potassium salt of Formula (I) in 1,4-dioxane;

2) optionally heating the resulting suspension;

3) isolating the resulting crystals;

4) optionally washing the isolated crystals with 1,4-dioxane; and

5) drying the isolated crystals, to give the crystalline anhydrate form of the potassium salt (I).

15. The method according to claim 14 , which comprises

1) digesting a hydrate or a mixture of hydrates of a potassium salt of Formula (I) in 1,4-dioxane;

2) heating the resulting suspension;

3) isolating the resulting crystals;

4) optionally washing the isolated crystals with 1,4-dioxane; and

5) drying the isolated crystals, to give the crystalline anhydrate form of the potassium salt (I).

16. The method according to claim 14 , which comprises

1) digesting a hydrate or a mixture of hydrates of a potassium salt of Formula (I) in 1,4-dioxane;

2) optionally heating the resulting suspension;

3) isolating the resulting crystals;

4) washing the isolated crystals with 1,4-dioxane; and

5) drying the isolated crystals, to give the crystalline anhydrate form of the potassium salt (I).

17. The method according to claim 14 , which comprises

1) digesting a hydrate or a mixture of hydrates of a potassium salt of Formula (I) in 1,4-dioxane;

2) heating the resulting suspension;

3) isolating the resulting crystals;

4) washing the isolated crystals with 1,4-dioxane; and

5) drying the isolated crystals, to give the crystalline anhydrate form of the potassium salt (I).

18. The method according to claim 1 , wherein the drying for preparing a crystalline potassium salt of 2-((2S,3R,4E,6E,10E,12S)-13-(4-fluorophenoxy)-2,3,12-trihydroxytrideca-4,6,10-trien-8-ynyloxy)acetate, which is

in the form of a monohydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.5 Å;

in the form of a monohydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.5 Å, about d=4.3 Å and about d=4.0 Å;

in the form of a dihydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=27.1 Å; or

in the form of a dihydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=27.1 Å, about d=4.2 Å and about d=4.1 Å,

occurs under conditions that correlate with the stability domain of the monohydrate form or of the dihydrate form to give the monohydrate form or the dihydrate dehydrate form, respectively, of the potassium salt.

19. The method according to claim 18 , wherein drying occurs under a sweep gas flow.

20. The method according to claim 1 , wherein the drying for preparing a crystalline potassium salt of 2-((2S,3R,4E,6E,10E,12S)-13-(4-fluorophenoxy)-2,3,12-trihydroxytrideca-4,6,10-trien-8-ynyloxy)acetate, which is

in the form of an anhydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.7 Å; or

in the form of an anhydrate characterized by a X-ray powder diffraction pattern having a characteristic peak at about d=26.7 Å and about d=3.7 Å;

occurs under conditions that correlate with the stability domain of the anhydrate form.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2019
From: BAYER INTELLECTUAL PROPERTY GMBH
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 048525/0665 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2014
From: HAAG, TILO; GROSSBACH, DANJA; WINTER, GABRIELE; SANDER, MICHAEL; BECKMANN, WOLFGANG; BARTEL, KLAUS; DINTER, CHRISTIAN
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 032942/0080 →
CHANGE OF NAME Recorded Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0668 →
CHANGE OF NAME Recorded Nov 11, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029277/0286 →